Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Baofei Granules for stable COPD with lung-spleen qi deficiency syndrome
CTR20211280Phase 2Completed
- Sponsor
- Henan University of Chinese Medicine
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Baofeikang in chronic obstructive pulmonary disease (COPD), sponsored by Henan University of Chinese Medicine. Started Sep 2021; status: completed.
02
Drugs
Baofeikang
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20211280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211280.